Paricalcitol

Product NDC: 0409-1008
11-digit product format: 004091008
Labeler code: 0409
Product ID: 0409-1008_1cf0245e-2ec9-4490-afa2-95b52fa79eec
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: PARICALCITOL
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Application: NDA201657
Marketing category: NDA
Marketing start: 2014-11-01
Marketing end: 0000-00-00
Substance: PARICALCITOL
Active strength: 5 ug/mL
Pharmacologic classes: Cholecalciferol [CS],Vitamin D3 Analog [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0409-1008		D	Discontinued by firm	2026-08-17
excluded package	package	0409-1008	0409-1008-01	D	Discontinued by firm	2026-08-17
excluded package	package	0409-1008	0409-1008-02	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-1008-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-1008-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-1008-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-1008-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-1008-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-1008-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-1008-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-1008-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-1008-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-1008-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-1008-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-1008-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-1008-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-1008-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-1008-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-1008-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-1008-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-1008-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-1008-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-1008-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-1008-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-1008-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-1008-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-1008-02	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
N201657-001	PARICALCITOL	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21
N201657-002	PARICALCITOL	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21
N201657-003	PARICALCITOL	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201657-002	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N201657-003	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N201657-001	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION / INTRAVENOUS	2014-10-21	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 81 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-05-31 18:47 UTC	2024-05	N201657-001	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N201657-002	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N201657-003	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N201657-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N201657-002	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N201657-003	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N201657-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N201657-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N201657-003	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N201657-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N201657-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N201657-003	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N201657-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N201657-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N201657-003	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N201657-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N201657-002	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N201657-003	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N201657-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N201657-002	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N201657-003	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N201657-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N201657-002	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N201657-003	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N201657-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N201657-002	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N201657-003	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N201657-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N201657-002	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N201657-003	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N201657-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N201657-002	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N201657-003	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N201657-001	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N201657-002	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N201657-003	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N201657-001	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N201657-002	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N201657-003	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N201657-001	AP	1	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-1008-01	ML - Milliliter	0409-1008	3d95fa14-abee-45b6-aeed-e0403fdaa9ff	1	2014-12-01
0409-1008-02	ML - Milliliter	0409-1008	41f0b9dd-db54-4fec-964a-b275f122bd52	1	2014-12-01
0409-1008-11	ML - Milliliter	0409-1008	04c97227-bf3f-447f-b921-e3890d435b9d	1	2014-12-01
0409-1008-12	ML - Milliliter	0409-1008	b7bbd3e9-dd50-4286-879e-d25d8ca88f8e	1	2014-12-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PARICALCITOL	ACTIVE INGREDIENT	6702D36OG5	PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.]	1
PARICALCITOL	ACTIVE MOIETY	6702D36OG5	PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6702D36OG5	PARICALCITOL	131918-61-1	PARICALCITOL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-1008-01	00409100801	25 VIAL, MULTI-DOSE in 1 TRAY (0409-1008-01) > 1 mL in 1 VIAL, MULTI-DOSE (0409-1008-11)	2014-11-01	0000-00-00	No	No	Current
0409-1008-02	00409100802	25 VIAL, MULTI-DOSE in 1 TRAY (0409-1008-02) > 2 mL in 1 VIAL, MULTI-DOSE (0409-1008-12)	2014-11-01	0000-00-00	No	No	Current